Cargando…
Activating Transcription Factor-5 Knockdown Reduces Aggressiveness of Mammary Tumor Cells and Attenuates Mammary Tumor Growth
Activating transcription factor-5 (ATF5) is an anti-apoptotic factor and has been implicated in enhancing the survival of cancer cells under stress and in regulating the autophagy process. Targeting ATF5 in anticancer therapy may be particularly attractive because of its differential role in cancer...
Autores principales: | Ben-Shmuel, Sarit, Rashed, Rola, Rostoker, Ran, Isakov, Elina, Shen-Orr, Zila, LeRoith, Derek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519529/ https://www.ncbi.nlm.nih.gov/pubmed/28785242 http://dx.doi.org/10.3389/fendo.2017.00173 |
Ejemplares similares
-
CD24 cell surface expression in Mvt1 mammary cancer cells serves as a biomarker for sensitivity to anti-IGF1R therapy
por: Rostoker, Ran, et al.
Publicado: (2016) -
Deep sequencing of mRNA in CD24(−) and CD24(+) mammary carcinoma Mvt1 cell line
por: Rostoker, Ran, et al.
Publicado: (2015) -
CD24(+) cells fuel rapid tumor growth and display high metastatic capacity
por: Rostoker, Ran, et al.
Publicado: (2015) -
Insulin-Sensitizing Therapy Attenuates Type 2 Diabetes–Mediated Mammary Tumor Progression
por: Fierz, Yvonne, et al.
Publicado: (2010) -
Silencing Vimentin Expression Decreases Pulmonary Metastases in a Pre-Diabetic Mouse Model of Mammary Tumor Progression
por: Zelenko, Zara, et al.
Publicado: (2016)